ADVERTISEMENT

Zydus Lifesciences - High Base To Keep Earnings Per Share Muted, Specialty Growth Key: HDFC Securities

The company's advancements in novel molecules, biosimilars, and vaccines provide long-term growth visibility, says the brokerage.

<div class="paragraphs"><p>&nbsp;(Photo source: Company website)</p></div>
 (Photo source: Company website)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to Unlock & Enjoy your 
Subscriber-Only
 benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More